Business
AstraZeneca launches new drug to prevent COVID symptoms – Sydney Morning Herald
The company behind one of Australia’s key COVID-19 vaccines has filed for approval in the US for a drug to fight the virus.
Pfizer launched a study of the drug in 2,660 patients last week. Its treatment is designed as a pill that is taken over five days at the first sign of infection or awareness of exposure to the virus, acting to block the activity of the enzyme the virus…
Continue Reading
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
General24 hours agoUS authorities to set targets to lower medicine prices
-
Noosa News12 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash